Lifestance Health Group (LFST) Q2 2025 earnings summary

Executive summary

• Q2 2025 revenue rose 11% year-over-year to $345.3 million, driven by clinician hiring, higher visit volumes, and improved productivity, with 2.2 million visits and a clinician base of 7,708.

• Net loss narrowed to $3.8 million from $23.3 million year-over-year, reflecting improved operating leverage and lower depreciation and amortization.

• Adjusted EBITDA increased 19% to $34.0 million (9.8% of revenue), highlighting improved operational efficiency.

• Free cash flow reached a record $56.6 million, with cash and equivalents at $188.9 million and net long-term debt at $273 million.

• Continued focus on expanding access to high-quality, affordable mental health care through organic growth, clinician recruiting, de novo center openings, and leveraging both in-person and virtual care models.

Financial highlights

• Center Margin grew 11% to $108.4 million (31.4% of revenue), and Adjusted EBITDA margin improved to 9.8% from 9.2% year-over-year.

• Net cash provided by operations was $64.4 million in Q2 2025; for the six months ended June 30, 2025, net cash from operations totaled $61.3 million.

• Cash and cash equivalents at quarter-end were $188.9 million; net long-term debt was $273 million.

• Total revenue per visit in Q2 2025 was $157.0, down 1% year-over-year due to a unique payer dynamic.

• Net loss margin improved to (1.1)% from (7.5)% year-over-year.

Outlook and guidance

• Full-year 2025 revenue guidance maintained at $1.4–$1.44 billion; Center Margin guidance raised to $441–$465 million; Adjusted EBITDA guidance raised to $140–$150 million.

• Q3 2025 guidance: revenue $345–$365 million, Center Margin $105–$119 million, Adjusted EBITDA $33–$39 million.

• Expect continued growth in clinician base, visit volumes, and modest rate improvement in the second half.

• Assumes 25–30 new center openings in 2025; M&A potential not included in guidance.

• Long-term margin target of 15%–20% as operating leverage and center margin expand.